Jury's out in Las Vegas after 3-month trial over Actos cancer risks | PharmaBoardroom

Jury's out in Las Vegas after 3-month trial over Actos cancer risks

face
TAGS: ,

In federal court in Las Vegas, a trial over the cancer risks of Takeda's Actos drug wrapped up Tuesday, leaving the jury to decide whether the diabetes remedy triggered the plaintiffs' disease–and if so, how much they should collect from the Japanese drugmaker.

Latest Report